Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Alexander Kamb(Integrated BioTherapeutics (United States)), Lisa Cannon‐Albright(University of Utah), Nicholas G. Martin(University of Wollongong), Nelleke A. Gruis(Leiden University), Charles E. Hussey(Myriad (Germany)), David E. Anderson(University of Tennessee at Knoxville), Philippa Youl(QIMR Berghofer Medical Research Institute), Joanne F. Aitken(Cancer Council Queensland), Adèle C. Green(QIMR Berghofer Medical Research Institute), Robert MacLennan(QIMR Berghofer Medical Research Institute), Donna Shattuck-Eidens(Myriad (Germany)), Wei Ding(Mayo Clinic), John J. Zone(University of Utah), Yoshio Miki(Japanese Foundation For Cancer Research), David E. Goldgar(University of Utah), Qingqing Liu(Chengdu University of Traditional Chinese Medicine), Thanh V. Tran(Myriad (Germany)), Laurence J. Meyer(University of Utah), M McClure(Myriad (Germany)), W. Bergman(Leiden University Medical Center), Mark H. Skolnick, Jane Weaver-Feldhaus(Myriad (Germany)), Rune R. Frants(Leiden University), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust)
Cited by 850
Related Papers
Construction of a genetic linkage map in man using restriction fragment length polymorphisms.
|PubMed|1980|8.4k
Identification of FAP Locus Genes from Chromosome 5q21
|Science|1991|2.4k
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
|Nature Genetics|2018|2.3k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k